M1019 HCPCS code: Adolescent patients 12 to 17 years of age with major depression or dysthymia who reached remission at twelve months as demonstrated by a twelve month (+/-60 days) phq-9 or phq-9m score of less than 5
M1019 is the HCPCS Level II code for adolescent patients 12 to 17 years of age with major depression or dysthymia who reached remission at twelve months as demonstrated by a twelve month (+/-60 days) phq-9 or phq-9m score of less than 5. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case.
Code details
| Field | Value |
|---|---|
| Section | M codes — Medical services and quality measures |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 00 — Not separately priced by Medicare |
| BETOS category | Z2 |
| Added | 2019-01-01 |
| Last action effective | 2019-01-01 |
What changed for M1019
- 2019-01-01: M1019 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code M1019?
M1019 is the HCPCS Level II code for adolescent patients 12 to 17 years of age with major depression or dysthymia who reached remission at twelve months as demonstrated by a twelve month (+/-60 days) phq-9 or phq-9m score of less than 5. Short descriptor: "Adl pt mj dep ds rs 12 phq<5".
Does Medicare cover M1019?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
Related M10 codes
- M1000 — Pain screened as moderate to severe
- M1001 — Plan of care to address moderate to severe pain documented on or before the date of the second visit with a clinician
- M1002 — Plan of care for moderate to severe pain not documented on or before the date of the second visit with a clinician, reason not given
- M1003 — Tb screening performed and results interpreted within twelve months prior to initiation of first-time biologic and/or immune response modifier therapy
- M1004 — Documentation of medical reason for not screening for tb or interpreting results (i.e., patient positive for tb and documentation of past treatment; patient who has recently completed a course of anti-tb therapy)
- M1005 — Tb screening not performed or results not interpreted, reason not given
- M1006 — Disease activity not assessed, reason not given
- M1007 — >=50% of total number of a patient's outpatient ra encounters assessed
- M1008 — <50% of total number of a patient's outpatient ra encounters assessed
- M1009 — Discharge/discontinuation of the episode of care documented in the medical record
- M1010 — Discharge/discontinuation of the episode of care documented in the medical record
- M1011 — Discharge/discontinuation of the episode of care documented in the medical record
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under M1019
- Watch M1019 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for M1019
Sources: CMS HCPCS Level II release October 2025; CMS DMEPOS fee schedule; CMS NCCI MUE tables; CMS Medicare utilization (physician and DME supplier files); CMS Medicare Coverage Database articles. Fees are Medicare allowables, not commercial rates. Not billing or legal advice.